Medtronic TAVR outperforms surgical valve replacement in study

Medtronic today announced positive four-year results from a trial of its Evolut transcatheter aortic valve replacement (TAVR) system.

Related Keywords

San Francisco ,California ,United States ,Nina Goodheart , ,Journal Of The American College Cardiology ,Medtronic ,Transcatheter Cardiovascular Therapeutics ,American College ,Evolut Low Risk Trial ,Structural Heart ,